Evidence map›Paper›PMID 40210980›Full record

ArticleScientific reports2025

Non-communicable diseases in the WHO African region: analysis of risk factors, mortality, and responses based on WHO data.

Abbie Barry, Benido Impouma, Caitlin M Wolfe, Adriana Campos, Nicola Carey Richards, Akpaka Kalu, Cheick Bady Diallo, Prebo Barango, Bridget Farham

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abbie BarryWorld Health Organization Regional Office for Africa, B.P. 06 Cité de Djoué, Brazzaville, Congo. abbiebarry9@gmail.com.
Benido ImpoumaWorld Health Organization Regional Office for Africa, B.P. 06 Cité de Djoué, Brazzaville, Congo.
Caitlin M WolfeWorld Health Organization Regional Office for Africa, B.P. 06 Cité de Djoué, Brazzaville, Congo.
Adriana CamposWorld Health Organization Regional Office for Africa, B.P. 06 Cité de Djoué, Brazzaville, Congo.
Nicola Carey RichardsWorld Health Organization Regional Office for Africa, B.P. 06 Cité de Djoué, Brazzaville, Congo.
Akpaka KaluWorld Health Organization Regional Office for Africa, B.P. 06 Cité de Djoué, Brazzaville, Congo.
Cheick Bady DialloWorld Health Organization Regional Office for Africa, B.P. 06 Cité de Djoué, Brazzaville, Congo.
Prebo BarangoWorld Health Organization Headquarters (HQ), Geneva, Switzerland.
Bridget FarhamWorld Health Organization Regional Office for Africa, B.P. 06 Cité de Djoué, Brazzaville, Congo.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Historically overshadowed by communicable diseases, the burden of non-communicable diseases (NCDs) has surged over the past two decades, posing a significant threat to public health, and necessitating urgent attention. This study examines the mortality burden from four major groups/categories of NCDs including cancers, cardiovascular diseases (CVD), chronic respiratory diseases (CRD) and diabetes, prevalence of four NCD associated risk factors including tobacco use, alcohol consumption, physical inactivity and overweight, availability of NCD essential medicines and progress indicators of the NCD response in the WHO African region. The data used in this study were obtained from the WHO NCD data portal, Global Health Observatory, and Global Health Estimates, covering the most recent available data for each indicator, ranging from 2000 to 2019 to assess how trends in NCD mortality burden have evolved, as well as the current status of the four main risk factors, availability of essential medicines, and key NCD response indicators. The analysis focused on descriptive statistics for globally used, disease-specific key indicators to examine trends and variations across countries: (i) age-standardized mortality rates (ASMR) for major NCDs (cancers, CRD, CVD and diabetes), (ii) prevalence of NCD risk factors (tobacco use, alcohol consumption, physical inactivity, and overweight), (iii) availability of essential medicines for NCDs in public health facilities, and (iv) national NCD response indicators, such as the presence of NCD targets, mortality data, risk factor reduction measures, and surveillance. Mortality was reported as ASMR or percentages; risk factors as prevalence, except alcohol (litres per capita). Changes in mortality were calculated as absolute and relative differences, with tables and figures generated in Microsoft Excel. Between 2000-2019, NCD-related deaths and the percentage of deaths due to NCDs increased from 24.2 to 37.1% resulting in 12.9 and 53.3% absolute and relative increases. The ASMR decreased by 130.6 per 100,000 population resulting in an 18.2% relative decrease, during the same period; however, it remains consistently higher than the global average. In 2019, 64% of NCD deaths were among people 70 years or younger and the percentage of premature deaths from NCDs ranged from 36.5 to 72.1%. Despite the burden of NCDs, the availability of essential medicines and health services was sub-optimal in public health facilities. The prevalence of key risk factors such as tobacco use, physical inactivity, overweight, and alcohol consumption per capita varied by sex and across the region, with the prevalence of tobacco use and consumption of alcohol higher among men, while the prevalence of insufficient physical activity and overweight higher among women. Public health responses to NCDs remained sub-optimal due to limited national NCD targets, inadequate surveillance, risk factor reduction measures, and access to essential medicines. Though the NCD ASMR has decreased, there has been an increase in NCD-related deaths and the percentage of deaths due to NCDs over the last two decades in the WHO African Region. The mortality burden of NCDs and the prevalence of risk factors remains relatively high, while mounting a public health response for preventing and controlling these NCDs remains challenging. Accelerated action is essential to meet global and regional NCD reduction targets. Strengthening national NCD targets, improving surveillance, ensuring access to essential medicines, and scaling up risk factor reduction strategies are critical to reversing current trends and achieving the 2030 SDG NCD targets.

Indexed as

Noncommunicable DiseasesAdultAfricaAlcohol DrinkingCardiovascular DiseasesDiabetes MellitusFemaleHumansMaleMiddle AgedNeoplasmsPrevalenceRisk FactorsWorld Health OrganizationBehavioural risk factorsCardiovascular diseases (CVD)Chronic respiratory diseases (CRD)DiabetesHypertensionNon-communicable diseases (NCDs)

Identifiers

PMID40210980
PMCPMC11986008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.